Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 31,517 | 20,901 | 19,801 | 19,198 | 19,316 |
| Operating Income | -31,517 | -20,901 | -19,742 | -19,198 | -19,316 |
| Other Income | -4,823 | 1,283 | 6,152 | -11,416 | -1,433 |
| Pre-tax Income | -36,340 | -19,618 | -13,590 | -30,614 | -20,749 |
| Income Tax | 18 | 12 | 130 | 11 | 16 |
| Net Income Continuous | -36,358 | -19,630 | -13,720 | -30,625 | -20,765 |
| Net Income | $-36,358 | $-19,630 | $-13,720 | $-30,625 | $-20,765 |
| EPS Basic Total Ops | -0.83 | -0.98 | -0.48 | -2.19 | -1.92 |
| EPS Basic Continuous Ops | -0.83 | -0.98 | -0.48 | -2.19 | -1.92 |
| EPS Diluted Total Ops | -0.83 | -0.98 | -0.48 | -2.19 | -1.92 |
| EPS Diluted Continuous Ops | -0.83 | -0.98 | -0.48 | -2.19 | -1.92 |
| EPS Diluted Before Non-Recurring Items | -0.83 | -0.98 | -0.37 | -2.19 | -1.92 |
| EBITDA(a) | $-31,500 | $-20,884 | $-19,785 | $-19,139 | $-19,182 |